{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:01:56Z","timestamp":1771063316098,"version":"3.50.1"},"reference-count":74,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011723","name":"Myeloma UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Treatment advances have greatly improved survival, but myeloma is among the worst of all cancers for delayed diagnosis, causing serious morbidities and early deaths. This delay is largely because the symptom profile of myeloma has very low specificity, and in primary care, myeloma is rare. However, initiating the journey to diagnosis simply requires considering myeloma and sending blood to test for monoclonal immunoglobulin. Laboratory tests reliably detect monoclonal immunoglobulin, which is present in 99% of myeloma cases, so why do health care systems have such a problem with delayed diagnosis? The Myeloma UK early diagnosis programme has brought together diverse expertise to investigate this problem, and this article was prepared by the programme's working group for laboratory best practice. It reviews evidence for test requesting, analysis and reporting, for which there is large variation in practice across the United Kingdom. It presents a \u2018GP Myeloma diagnostic tool\u2019 and how it can be integrated into laboratory practice alongside a laboratory best practice tool. It proposes improved requesting and integration with haematology services for reporting and interpretation. Here the laboratory has a central role in creating efficient and cost\u2010effective pathways for appropriate and timely bone marrow examination for myeloma diagnosis.<\/jats:p>","DOI":"10.1111\/bjh.19224","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:24:05Z","timestamp":1704241445000},"page":"476-486","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services"],"prefix":"10.1111","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-7564","authenticated-orcid":false,"given":"Mark","family":"Drayson","sequence":"first","affiliation":[{"name":"Clinical Immunology Service University of Birmingham  Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Jennis","sequence":"additional","affiliation":[{"name":"Myeloma UK  Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Laketic\u2010Ljubojevic","sequence":"additional","affiliation":[{"name":"Myeloma UK  Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Patel","sequence":"additional","affiliation":[{"name":"UK NEQAS Immunology, Immunochemistry &amp; Allergy Sheffield Teaching Hospitals  Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-2852","authenticated-orcid":false,"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[{"name":"Cancer Research UK Clinical Trials Unit University of Birmingham  Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Renwick","sequence":"additional","affiliation":[{"name":"Myeloma UK  Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Richter","sequence":"additional","affiliation":[{"name":"Clinical Immunology Service University of Birmingham  Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Protein Reference Unit, South West London Pathology St Georges Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Sheldon","sequence":"additional","affiliation":[{"name":"Protein Reference Unit, South West London Pathology St Georges Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Sadler","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Stapleton","sequence":"additional","affiliation":[{"name":"North Devon District Hospital  Barnstaple UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenella","family":"Willis","sequence":"additional","affiliation":[{"name":"St George's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairi","family":"Whiston","sequence":"additional","affiliation":[{"name":"Myeloma UK  Edinburgh UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for Myeloma UK working group for laboratory best practice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00135-5"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2128"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.4314\/gmj.v53i1.8"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.138"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70041-4"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/2052-1839-13-9"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902741471"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2016.06.150393"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja15.01169"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm077"},{"key":"e_1_2_5_13_1","unstructured":"National Cancer Intelligence Network.Routes to Diagnosis 2006\u20132016 Workbook.2016[Cited 2021 Nov 13]. Available from:http:\/\/www.ncin.org.uk\/publications\/routes_to_diagnosis"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.304"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp15X683545"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.11.005"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17044"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17410"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)86528-X"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0926-6585(65)90021-X"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.121.4.561"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.4.673"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12457-9"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.9.2900"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013794"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2020.101142"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14753"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-008953"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003807"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.168"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010080857"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.14"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2020-001085"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007608"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06969.x"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.60"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1038"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-505487"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07929.x"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709974"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60482-5"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.014"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010066"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-839480"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0077-4"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0301212"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-252072"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00021-11"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1998.tb01075.x"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.23"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.09.004"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-5-391"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113621"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00480-w"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102021\u2010152333"},{"key":"e_1_2_5_56_1","unstructured":"GhobrialI.Predicting Progression of Developing Myeloma in a High\u2010Risk Screened Population (PROMISE). Available from:https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03689595https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03689595"},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224360"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/48.9.1437"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u20102369\u20109\u201011"},{"key":"e_1_2_5_60_1","unstructured":"Myeloma: diagnosis and management NICE guideline [NG35].2016."},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.05.001"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.307"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314924"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04192.x"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39576.709711.80"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-015-1223-y"},{"key":"e_1_2_5_67_1","unstructured":"https:\/\/academy.myeloma.org.uk\/resources\/gp\u2010myeloma\u2010diagnostic\u2010tool\/"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.189159"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-726778"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-495929"},{"key":"e_1_2_5_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13156"},{"key":"e_1_2_5_72_1","doi-asserted-by":"publisher","DOI":"10.1258\/000456307782268084"},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1258\/0004563001899690"},{"key":"e_1_2_5_74_1","unstructured":"SternS ChaudhuriS DraysonM HenshawS KarunanithiK WillisF et\u00a0al.Investigation and management of the monoclonal gammopathy of undetermined significance (MGUS). A British Society for Haematology Good Practice Paper."},{"key":"e_1_2_5_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.843.843"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T06:04:08Z","timestamp":1707285848000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1111\/bjh.19224"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19224","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"2023-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}